অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; titanium dioxide; iron oxide yellow; gelatin - ursodox gh (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: hypromellose; gelatin; ethanol absolute; lactose; titanium dioxide; purified water; magnesium stearate; methyl chloride; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: gelatin; magnesium stearate; titanium dioxide; methyl chloride; iron oxide yellow; hypromellose; purified water; lactose; croscarmellose sodium; ethanol absolute; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: hypromellose; titanium dioxide; ethanol absolute; gelatin; purified water; magnesium stearate; lactose; croscarmellose sodium; methyl chloride; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: gelatin; croscarmellose sodium; titanium dioxide; methyl chloride; iron oxide yellow; ethanol absolute; hypromellose; lactose; purified water; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; lactose; methyl chloride; titanium dioxide; hypromellose; magnesium stearate; ethanol absolute; purified water; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: methyl chloride; gelatin; magnesium stearate; purified water; ethanol absolute; hypromellose; titanium dioxide; croscarmellose sodium; lactose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 40902 - patient positioning device, diagnostic imaging/radiotherapy, whole body - a device comprising fixed or adjustable position elements, e.g. frames or boards, that are specifically designed to ensure adequate positioning and/or immobilization of the patient's whole body during imaging, image guided surgical or interventional procedures and/or radiation therapy procedures. it is also used to facilitate reproducible positioning for serial imaging studies or serial radiation therapy treatments.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride tablets are contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardi

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

mylan institutional inc. - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride tablets are contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardi